Plain-English translation of NCT06490432 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at heart rhythm problems that can happen in people who have metabolic dysfunction-associated steatotic liver disease (MASLD), which is a condition where fat builds up in the liver. Researchers want to understand what types of heart rhythm abnormalities occur in these patients and what factors put them at higher risk. By studying this connection, doctors hope to better care for people who have both liver and heart concerns.
Many people with fatty liver disease also experience heart rhythm problems, but doctors don't fully understand how often these problems happen or what puts certain patients at higher risk. This research could help identify patients who need heart monitoring and lead to better ways to prevent or manage these complications.
As a participant, you would likely visit the hospital for heart monitoring tests, such as an electrocardiogram (EKG) or possibly longer-term heart rhythm monitoring, along with standard medical evaluations. The study will track information about your heart rhythm patterns and your medical history. Based on the study design, you would not be receiving a new medication, but rather being observed to help researchers understand the connection between your liver condition and any heart rhythm changes.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Egypt
Enrollment target
~100 participants
Started
July 2024
Primary completion
July 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Asmaa Rashwan Ahmed, doctor
Sohag University